Published in:
01-12-2020 | COVID-19 | Research Letter
The Adaptive COVID-19 Treatment Trial-1 (ACTT-1) in a real-world population: a comparative observational study
Authors:
Matilde Tejlbo Frost, Espen Jimenez-Solem, Mikkel Zöllner Ankarfeldt, Martin Erik Nyeland, Anne Helms Andreasen, Tonny Studsgaard Petersen
Published in:
Critical Care
|
Issue 1/2020
Login to get access
Excerpt
The recently published ‘Adaptive COVID-19 Treatment Trial’ (ACTT-1) showed that remdesivir is a promising treatment option against coronavirus disease 2019 (COVID-19) [
1]. Consequently, remdesivir is now being evaluated for implementation in clinical practice worldwide. …